IRIS
MONTELEONE, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 78.843
AS - Asia 10.945
EU - Europa 8.096
SA - Sud America 1.546
AF - Africa 184
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 21
Totale 99.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 78.543
SG - Singapore 5.674
CN - Cina 2.088
BR - Brasile 1.288
IT - Italia 1.276
RU - Federazione Russa 1.170
HK - Hong Kong 1.144
DE - Germania 1.052
UA - Ucraina 947
IE - Irlanda 831
VN - Vietnam 788
FI - Finlandia 584
FR - Francia 539
GB - Regno Unito 536
SE - Svezia 352
PL - Polonia 294
JP - Giappone 256
KR - Corea 250
CA - Canada 160
IN - India 145
NL - Olanda 114
AR - Argentina 95
BD - Bangladesh 94
MX - Messico 89
ID - Indonesia 86
AT - Austria 67
ES - Italia 65
BE - Belgio 64
TR - Turchia 64
IQ - Iraq 63
ZA - Sudafrica 63
EC - Ecuador 37
LT - Lituania 34
CL - Cile 31
PK - Pakistan 29
PH - Filippine 26
UZ - Uzbekistan 26
AU - Australia 25
SA - Arabia Saudita 25
CH - Svizzera 24
PY - Paraguay 24
TN - Tunisia 24
VE - Venezuela 23
CO - Colombia 22
RO - Romania 22
CZ - Repubblica Ceca 20
IL - Israele 20
MA - Marocco 20
EG - Egitto 17
IR - Iran 15
AE - Emirati Arabi Uniti 14
GR - Grecia 14
JO - Giordania 14
DZ - Algeria 13
EU - Europa 13
KE - Kenya 13
KZ - Kazakistan 13
MY - Malesia 13
TH - Thailandia 13
AZ - Azerbaigian 12
SC - Seychelles 12
DO - Repubblica Dominicana 11
KG - Kirghizistan 11
PE - Perù 10
NO - Norvegia 9
RS - Serbia 9
DK - Danimarca 8
TW - Taiwan 8
AL - Albania 7
BG - Bulgaria 7
CR - Costa Rica 7
ET - Etiopia 7
NP - Nepal 7
UY - Uruguay 7
HN - Honduras 6
LB - Libano 6
LK - Sri Lanka 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
JM - Giamaica 5
MK - Macedonia 5
OM - Oman 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
A1 - Anonimo 4
BH - Bahrain 4
BO - Bolivia 4
DM - Dominica 4
EE - Estonia 4
GE - Georgia 4
GY - Guiana 4
HR - Croazia 4
HU - Ungheria 4
KW - Kuwait 4
PA - Panama 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BY - Bielorussia 3
GA - Gabon 3
Totale 99.612
Salva come PNG Salva come JPEG
Città #
Woodbridge 21.556
Wilmington 18.736
Houston 18.074
Singapore 2.740
Fairfield 2.603
Ann Arbor 2.020
Ashburn 1.735
Chandler 1.290
San Jose 1.245
Hong Kong 1.124
Seattle 1.054
Cambridge 863
Jacksonville 830
Beijing 800
Dublin 747
Medford 593
Rome 472
Dearborn 453
Council Bluffs 431
Santa Clara 422
The Dalles 402
Helsinki 353
New York 317
Los Angeles 297
Lawrence 273
Ho Chi Minh City 227
Kraków 221
Tokyo 220
Hanoi 195
Lauterbourg 180
Buffalo 173
Moscow 165
Zhengzhou 154
San Diego 152
Dallas 137
São Paulo 132
Menlo Park 118
Milan 108
Chicago 107
London 102
Mülheim 97
Nuremberg 80
Munich 71
Boardman 67
Redondo Beach 63
Warsaw 63
Brussels 60
Orem 60
Redwood City 60
North Bergen 58
Rio de Janeiro 58
Jakarta 57
Montreal 57
Shanghai 54
Seoul 53
Mountain View 52
Frankfurt am Main 48
Chennai 47
Toronto 47
Brooklyn 46
Colorado Springs 44
Norwalk 44
Johannesburg 43
Columbus 41
San Mateo 41
Atlanta 39
Denver 38
Verona 37
Phoenix 36
Vienna 36
University Park 35
Da Nang 34
Belo Horizonte 33
Haiphong 32
Lappeenranta 32
Palo Alto 32
San Francisco 32
Amsterdam 31
Guangzhou 31
Indianapolis 31
Falls Church 30
Baghdad 29
Hangzhou 29
Poplar 27
Hefei 26
Nanjing 26
Stockholm 26
Kunming 24
Manchester 24
Boston 23
Mexico City 23
Tashkent 23
Curitiba 21
Detroit 21
Dhaka 21
Mumbai 21
Naples 19
Brasília 18
Del Norte 18
Paris 18
Totale 84.208
Salva come PNG Salva come JPEG
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 610
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 605
Appropriate nutrient supplementation in celiac disease 604
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 575
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 564
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 555
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 549
Aryl hydrocarbon receptor and colitis 520
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 515
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 510
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 506
Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells 504
Interleukin-34 sustains inflammatory pathways in the gut 501
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 500
Regulation of gut inflammation and Th17 cell response by interleukin-21 498
Role of interleukin-21 in inflammation and allergy 498
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 496
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 495
Characterization of IL-17A-producing cells in celiac disease mucosa 494
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 486
No change in the mucosal gut microbiome is associated with celiac disease-specific microbiome alteration in adult patients 485
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 484
IL-21 comes of age as a regulator of effector T cells in the gut 479
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 479
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 478
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 478
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 477
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 476
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 475
The dual role of Smad7 in the control of cancer growth and metastasis 474
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 473
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 472
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 472
The gut-skin axis in health and disease: A paradigm with therapeutic implications 472
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 470
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 469
Activated STAT4 and a functional role for IL-12 in human Peyer's patches 468
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 464
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease 463
Colorectal cancer chemoprevention by mesalazine and its derivatives 462
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 461
Autocrine regulation of IL-21 production in human T lymphocytes 461
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 461
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 460
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 459
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 459
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 459
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 458
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 458
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 458
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 458
Tofacitinib for the treatment of ulcerative colitis 458
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 458
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 457
An overview of the role of innate lymphoid cells in gut infections and inflammation 457
Immunity, inflammation, and allergy in the gut 455
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 455
Bacteria and mucosal immunity 454
Targeting interleukin-21 in immune-mediated pathologies 454
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 454
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 453
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 453
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy 452
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 451
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 450
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 450
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 449
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 449
Antisense approach to inflammatory bowel disease: Prospects and challenges 448
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 448
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 447
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease 447
Collagen matrix injection combined with flap repair for complex anal fistula 445
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 445
Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 444
Interleukin-21 (IL-21) controls inflammatory pathways in the gut 443
IL-21 in the pathogenesis and treatment of skin diseases 442
null 442
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts T-reg cells via regulation of MIP-3 alpha 440
IL-21 regulates experimental colitis by modulating the balance between T-reg and Th17 cells 440
The dual role of inflammation in colon carcinogenesis 440
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 440
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 439
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 437
Defective expression of scavenger receptors in celiac disease mucosa 437
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 435
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures 435
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 434
TGF-beta 1 and Smad7 in the regulation of IBD 433
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 432
Role of Smad7 in inflammatory bowel diseases 432
Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease 432
New players in the cytokine orchestra of inflammatory bowel disease 431
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 431
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 431
Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease 431
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 430
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 430
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism 430
Emerging immunological targets in inflammatory bowel disease 430
Totale 46.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.145 0 0 0 0 0 0 0 0 0 461 472 212
2021/20222.938 144 238 122 167 81 256 131 115 382 289 209 804
2022/20233.485 354 296 67 436 324 799 293 225 326 74 199 92
2023/20241.248 157 42 86 43 125 250 77 205 19 19 33 192
2024/20258.712 227 1.670 938 534 197 766 533 372 824 710 1.142 799
2025/202612.656 1.055 638 1.445 1.157 1.306 679 1.754 1.733 1.638 1.251 0 0
Totale 100.833